Medtronic and the FDA left an insulin pump with a potentially deadly vulnerability on the market—until researchers who found the flaw showed how bad it could be.

This newest insulin pump system offers the company's most advanced SmartGuard™ technology, as featured in the MiniMed™ 670G system, with the added benefits of smartphone connectivity and an ...

DUBLIN - August 11, 2016 - Medtronic plc (MDT), the global leader in medical technology, today announced the U.S. commercial launch of its MiniMed 630G system with SmartGuard technology FDA approved ...

DUBLIN - August 11, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. commercial launch of its MiniMed 630G system with SmartGuard technology FDA ...

The MiniMed TM 670G gained approval in 2016 for people ages 14 and older and in 2018 for children ages 7 to 13 years, he said. Since then, use of the MiniMed TM 670G has grown to more than 180,000 ...

FDA Approves Medtronic MiniMed™ 780G System - World's First Insulin Pump with Meal Detection Technology* Featuring 5-Minute Auto Corrections†§ Apr. 21, 2023 4:58 PM ET Medtronic plc (MDT) ...

Two years after submitting the MiniMed 780G system for FDA approval, Medtronic finally secured the agency’s signoff to begin selling it in the U.S.

Medtronic plc’s insulin pump adds more than six hours to the time-in-range for people with type 1 diabetes compared to the current standard of care, a recently published study found. The closed loop ...

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

The Medtronic pumps affected by the alert are: the MiniMed 508; MiniMed Paradigm models 511, 512/712, 712E, 515/715, 522/722, 522K/722K; plus Paradigm 523/723 and 523K/723K pumps with software ...